0.92

3.35% 0.0298

After Hours: .94 0.02 +2.17%

Marker Therapeutics Inc (MRKR)

Overview News Price History Financials Discussions Forecast Stock Split

Marker Therapeutics Inc stock is traded at $0.92, with a volume of 120.15K. It is up +3.35% in the last 24 hours and down -21.37% over the past month. Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Previous Close:

$0.8902

Open:

$0.9571

24h Volume:

120.15K

Relative Volume:

1.26

Market Cap:

$15.34M

Revenue:

$3.20M

Net Income/Loss:

$-10.90M

P/E Ratio:

-1.3654

EPS:

-0.6738

Net Cash Flow:

$-7.92M

1W Performance:

-3.16%

1M Performance:

-21.37%

6M Performance:

-41.77%

1Y Performance:

-12.38%

1-Day Range:

$0.88

$0.9595

1-Week Range:

$0.88

$1.03

52-Week Range:

$0.84

$2.46

Marker Therapeutics Inc Stock (MRKR) Company Profile

Name

Marker Therapeutics Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

(713) 400-6400

Address

2450 HOLCOMBE BLVD, HOUSTON, TX

Employee

Twitter

@MRKRTherapeutic

Next Earnings Date

2026-11-12

Latest SEC Filings

MRKR's Discussions on Twitter

Compare MRKR vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRKR Marker Therapeutics Inc	0.92	15.34M	3.20M	-10.90M	-7.92M	-0.6738
VRTX Vertex Pharmaceuticals Inc	508.75	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.34	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.27	53.22B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.08	42.32B	5.76B	514.49M	1.10B	4.4813

Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-05-25	Initiated	Canaccord Genuity	Buy
Mar-25-21	Initiated	Piper Sandler	Overweight
Mar-19-21	Initiated	Cantor Fitzgerald	Overweight
May-12-20	Downgrade	Piper Sandler	Overweight → Neutral
May-30-19	Initiated	ROTH Capital	Buy
Mar-01-19	Initiated	Janney	Buy
Dec-03-18	Upgrade	Piper Jaffray	Neutral → Overweight

View All

Marker Therapeutics Inc Stock (MRKR) Latest News

Oct 05, 2026

Cerenome (Nasdaq:CNSY)Análisis de acciones - Simply Wall Street

Oct 05, 2026

Sep 22, 2026

Marker Therapeutics, Inc. Highlights Expanded Manufacturing Capabilities Supporting Mt-601 - marketscreener.com

Sep 22, 2026

Sep 18, 2026

Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan

Sep 18, 2026

Sep 10, 2026

CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - Business Upturn

Sep 10, 2026

CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - The Manila Times

Sep 10, 2026

Sep 04, 2026

Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeIV Rank - dars.gov.et

Sep 04, 2026

Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeVolume Spike Alerts - siam.in

Sep 04, 2026

Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeUndervalued Stocks - dars.gov.et

Sep 04, 2026

Aug 28, 2026